Androgen receptor expression in breast cancer patients tested for <i>BRCA1</i> and <i>BRCA2</i> mutations

Abstract

Approximately one in five BRCA1 mutated breast cancers negative for ER and PR express androgen receptors. Modulation of AR might open a new avenue for treating these high-risk cancers.